Advertisement
Case report| Volume 28, ISSUE 12, P1053-1057, December 15, 1990

Hypersensitivity to m-chlorophenylpiperazine in a subject with subclinical panic attacks

DOI:https://doi.org/10.1016/0006-3223(90)90606-3
Hypersensitivity to m-chlorophenylpiperazine in a subject with subclinical panic attacks
Previous ArticleTemporal relationship between clinical changes and MAT changes following ECT
Next ArticleGlycinamide ribonucleotide synthetase activity in lymphocytes from patients with Alzheimer's disease and normal controls
      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Caccia S.
        • Ballabio M.
        • Samanin R.
        • Zanini M.G.
        • Garratini S.
        MCPP, a central 5HT agonist, is a metabolite of trazodone.
        J Clin Pharm Pharmacol. 1981; 33: 477-478
        • Charney D.S.
        • Woods S.W.
        • Goodman W.K.
        • Heninger G.R.
        Serotonin function in axiety II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects.
        Psychopharmacology. 1987; 92: 14-24
        • Cowley D.S.
        • Dager S.R.
        • Foster S.I.
        • Dunner D.L.
        Clinical characteristics and response to sodium lactate of patients with infrequent panic attacks.
        Am J Psychiatry. 1987; 144: 795-798
        • Endicott F.
        • Spitzer R.L.
        A diagnostic interview: The Schedule for Affective Disorders and Schizophrenia.
        Arch Gen Psychiatry. 1978; 35: 837-844
        • Hamik A.
        • Petroutka S.J.
        1-m-cholorophenylpiperazine (MCPP) interactions with neurotransmitter receptors in the human brain.
        Biol Psychiatry. 1989; 25: 569-575
        • Hoyer D.
        Functional correlates of serotonin 5HT1 recognition sites.
        J Recept Res. 1988; 8: 59-81
        • Kahn R.S.
        • van Praag H.M.
        • Wetzler S.
        • Asnis G.M.
        • Barr G.
        Serotonin and anxiety revisited.
        Biol Psychiatry. 1988; 23: 189-208
        • Kahn R.S.
        • Wetzler S.
        • van Praag H.M.
        • Asnis G.M.
        Behavioral indications for serotonin receptor hypersensitivity in panic disorder.
        Psychiatry Res. 1988; 25: 101-104
        • Kahn R.S.
        • Asnis G.M.
        • Wetzler S.
        • van Praag H.M.
        Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder.
        Psychopharmacology. 1988; 96: 360-364
        • Kahn R.S.
        • Wetzler S.
        • Asnis G.M.
        • Kling M.A.
        • Suckow R.F.
        • van Praag H.M.
        The effects of m-chlorophenylpiperazine in normal subjects: A dose-response study.
        Psychopharmacology. 1990; 100: 339-344
        • Klein D.F.
        Delineation of two drug responsive anxiety syndromes.
        Psychopharmacologia. 1964; 5: 397-408
        • McNair D.M.
        • Lorr M.
        • Droppelman L.F.
        Manual for the Profile of Mood States. Educational and Industrial Testing Service, San Diego, CA1971
        • Mueller E.A.
        • Sunderland T.
        • Murphy D.L.
        Neuroendocrine effects of MCPP, a serotonin agonist, in humans.
        J Clin Endocrinol Metab. 1985; 61: 1179-1184
        • Mueller E.A.
        • Murphy D.L.
        • Sunderland T.
        Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: Evidence for a serotonin receptor-mediated mechanism of action in humans.
        Psychopharmacology. 1986; 89: 388-391
        • Norton R.G.
        • Harrison B.
        • Hauch J.
        • Rhodes L.
        Characteristics of people with infrequent panic attacks.
        J Abnorm Psychol. 1984; 94: 216-221
        • Spitzer R.L.
        • Endicott J.
        • Robins E.
        Research Diagnostic Criteria: Rationale and reliability.
        Arch Gen Psychiatry. 1978; 35: 773-782
        • Torgerson S.
        Genetic factors in anxiety disorders.
        Arch Gen Psychiatry. 1983; 40: 1085-1089

      Article info

      Publication history

      Received in revised form: March 8, 1990
      Received: October 5, 1989

      Identification

      DOI: https://doi.org/10.1016/0006-3223(90)90606-3

      Copyright

      © 1990 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX